The University of Chicago Header Logo

Connection

Fredric L. Coe to Female

This is a "connection" page, showing publications Fredric L. Coe has written about Female.
Connection Strength

0.996
  1. Relative contributions of urine sulfate, titratable urine anion, and GI anion to net acid load and effects of age. Physiol Rep. 2021 05; 9(10):e14870.
    View in: PubMed
    Score: 0.039
  2. Racial Differences in Risk Factors for Kidney Stone Formation. Clin J Am Soc Nephrol. 2020 08 07; 15(8):1166-1173.
    View in: PubMed
    Score: 0.037
  3. Evidence for disordered acid-base handling in calcium stone-forming patients. Am J Physiol Renal Physiol. 2020 02 01; 318(2):F363-F374.
    View in: PubMed
    Score: 0.035
  4. A laboratory-based algorithm to predict future kidney function decline in older adults with reduced estimated glomerular filtration rate?. Clin Nephrol. 2019 Sep; 92(3):113-122.
    View in: PubMed
    Score: 0.035
  5. Mechanism for higher urine pH in normal women compared with men. Am J Physiol Renal Physiol. 2018 04 01; 314(4):F623-F629.
    View in: PubMed
    Score: 0.031
  6. Increased Inlet Blood Flow Velocity Predicts Low Wall Shear Stress in the Cephalic Arch of Patients with Brachiocephalic Fistula Access. PLoS One. 2016; 11(4):e0152873.
    View in: PubMed
    Score: 0.027
  7. Biopsy proven medullary sponge kidney: clinical findings, histopathology, and role of osteogenesis in stone and plaque formation. Anat Rec (Hoboken). 2015 May; 298(5):865-77.
    View in: PubMed
    Score: 0.025
  8. Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat Rec (Hoboken). 2014 Apr; 297(4):731-48.
    View in: PubMed
    Score: 0.023
  9. Evidence for increased renal tubule and parathyroid gland sensitivity to serum calcium in human idiopathic hypercalciuria. Am J Physiol Renal Physiol. 2013 Sep 15; 305(6):F853-60.
    View in: PubMed
    Score: 0.023
  10. Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD. Nephrol Dial Transplant. 2012 Jul; 27(7):2847-53.
    View in: PubMed
    Score: 0.021
  11. Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am J Physiol Renal Physiol. 2011 Feb; 300(2):F311-8.
    View in: PubMed
    Score: 0.019
  12. Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int. 2010 Aug; 78(3):310-7.
    View in: PubMed
    Score: 0.018
  13. Characteristic differences in cephalic arch geometry for diabetic and non-diabetic ESRD patients. Nephrol Dial Transplant. 2009 Jul; 24(7):2190-4.
    View in: PubMed
    Score: 0.017
  14. Evidence for durable kidney stone prevention over several decades. BJU Int. 2009 May; 103(9):1238-46.
    View in: PubMed
    Score: 0.016
  15. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007 Feb; 177(2):565-9.
    View in: PubMed
    Score: 0.014
  16. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol. 2007 Jan; 292(1):F66-75.
    View in: PubMed
    Score: 0.014
  17. Urine calcium excretion predicts bone loss in idiopathic hypercalciuria. Kidney Int. 2006 Oct; 70(8):1463-7.
    View in: PubMed
    Score: 0.014
  18. Renal function in patients with nephrolithiasis. J Urol. 2006 Aug; 176(2):600-3; discussion 603.
    View in: PubMed
    Score: 0.014
  19. Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers. Am J Physiol Renal Physiol. 2006 Sep; 291(3):F530-6.
    View in: PubMed
    Score: 0.014
  20. Evidence against a contribution of conventional urine risk factors to de novo ESRD renal stones. Nephrol Dial Transplant. 2006 Mar; 21(3):701-6.
    View in: PubMed
    Score: 0.013
  21. Kidney stone disease. J Clin Invest. 2005 Oct; 115(10):2598-608.
    View in: PubMed
    Score: 0.013
  22. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int. 2005 Feb; 67(2):685-90.
    View in: PubMed
    Score: 0.013
  23. Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int. 2003 Dec; 64(6):2150-4.
    View in: PubMed
    Score: 0.012
  24. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int. 2003 Dec; 64(6):2204-13.
    View in: PubMed
    Score: 0.012
  25. Endoscopic renal papillary biopsies: a tissue retrieval technique for histological studies in patients with nephrolithiasis. J Urol. 2003 Dec; 170(6 Pt 1):2186-9.
    View in: PubMed
    Score: 0.012
  26. Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int. 2003 Jan; 63(1):255-65.
    View in: PubMed
    Score: 0.011
  27. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol. 2002 Jun; 167(6):2372-6.
    View in: PubMed
    Score: 0.010
  28. Urinary stone risk factors in the siblings of patients with calcium renal stones. J Urol. 2002 May; 167(5):1965-7.
    View in: PubMed
    Score: 0.010
  29. Reduced crystallization inhibition by urine from women with nephrolithiasis. Kidney Int. 2002 May; 61(5):1821-9.
    View in: PubMed
    Score: 0.010
  30. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol. 2002 Apr; 167(4):1607-12.
    View in: PubMed
    Score: 0.010
  31. Patient adherence to long-term medical treatment of kidney stones. J Urol. 2001 Dec; 166(6):2057-60.
    View in: PubMed
    Score: 0.010
  32. Agreement of Food Records and 24-Hour Urine Studies in Clinical Practice. J Ren Nutr. 2022 01; 32(1):51-57.
    View in: PubMed
    Score: 0.010
  33. Evidence for abnormal linkage between urine oxalate and citrate excretion in human kidney stone formers. Physiol Rep. 2021 07; 9(13):e14943.
    View in: PubMed
    Score: 0.010
  34. Discrepancy Between Stone and Tissue Mineral Type in Patients with Idiopathic Uric Acid Stones. J Endourol. 2020 03; 34(3):385-393.
    View in: PubMed
    Score: 0.009
  35. In Vivo Renal Tubule pH in Stone-Forming Human Kidneys. J Endourol. 2020 02; 34(2):203-208.
    View in: PubMed
    Score: 0.009
  36. A modified cyanide-nitroprusside method for quantifying urinary cystine concentration that corrects for creatinine interference. Clin Chim Acta. 1999 Nov; 289(1-2):57-68.
    View in: PubMed
    Score: 0.009
  37. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia. Kidney Int. 1999 Nov; 56(5):1879-85.
    View in: PubMed
    Score: 0.009
  38. Mechanisms for falling urine pH with age in stone formers. Am J Physiol Renal Physiol. 2019 07 01; 317(7):F65-F72.
    View in: PubMed
    Score: 0.008
  39. Association Between Randall's Plaque Stone Anchors and Renal Papillary Pits. J Endourol. 2019 04; 33(4):337-342.
    View in: PubMed
    Score: 0.008
  40. Medical reduction of stone risk in a network of treatment centers compared to a research clinic. J Urol. 1998 Nov; 160(5):1629-34.
    View in: PubMed
    Score: 0.008
  41. Randall's plaque in stone formers originates in ascending thin limbs. Am J Physiol Renal Physiol. 2018 11 01; 315(5):F1236-F1242.
    View in: PubMed
    Score: 0.008
  42. Renal stone disease in older adults. Clin Geriatr Med. 1998 May; 14(2):367-81.
    View in: PubMed
    Score: 0.008
  43. Evidence for a role of PDZ domain-containing proteins to mediate hypophosphatemia in calcium stone formers. Nephrol Dial Transplant. 2018 05 01; 33(5):759-770.
    View in: PubMed
    Score: 0.008
  44. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones. J Urol. 1998 Mar; 159(3):664-8.
    View in: PubMed
    Score: 0.008
  45. Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int. 1997 Dec; 52(6):1602-8.
    View in: PubMed
    Score: 0.008
  46. Papillary Ductal Plugging is a Mechanism for Early Stone Retention in Brushite Stone Disease. J Urol. 2018 01; 199(1):186-192.
    View in: PubMed
    Score: 0.008
  47. New insights into the pathophysiology and treatment of nephrolithiasis: new research venues. J Bone Miner Res. 1997 Apr; 12(4):522-33.
    View in: PubMed
    Score: 0.007
  48. Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int. 1997 Mar; 51(3):640-5.
    View in: PubMed
    Score: 0.007
  49. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 1997 Mar; 51(3):894-900.
    View in: PubMed
    Score: 0.007
  50. Endoscopic Evidence That Randall's Plaque is Associated with Surface Erosion of the Renal Papilla. J Endourol. 2017 01; 31(1):85-90.
    View in: PubMed
    Score: 0.007
  51. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis. J Am Soc Nephrol. 1996 Apr; 7(4):602-7.
    View in: PubMed
    Score: 0.007
  52. Stone formation in genetic hypercalciuric rats. Kidney Int. 1995 Dec; 48(6):1705-13.
    View in: PubMed
    Score: 0.007
  53. Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study. BMC Nephrol. 2015 Oct 15; 16:163.
    View in: PubMed
    Score: 0.007
  54. Sex differences in proximal and distal nephron function contribute to the mechanism of idiopathic hypercalcuria in calcium stone formers. Am J Physiol Regul Integr Comp Physiol. 2015 Jul 01; 309(1):R85-92.
    View in: PubMed
    Score: 0.006
  55. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low. J Nephrol. 2016 Feb; 29(1):63-70.
    View in: PubMed
    Score: 0.006
  56. Mechanism by which shock wave lithotripsy can promote formation of human calcium phosphate stones. Am J Physiol Renal Physiol. 2015 Apr 15; 308(8):F938-49.
    View in: PubMed
    Score: 0.006
  57. Idiopathic hypercalciuria: the contribution of Dr. Jacob Lemann, Jr. J Am Soc Nephrol. 1994 Nov; 5(5 Suppl 1):S59-69.
    View in: PubMed
    Score: 0.006
  58. Effect of renal transplantation on serum oxalate and urinary oxalate excretion. Nephron. 1994; 67(4):414-8.
    View in: PubMed
    Score: 0.006
  59. Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int. 1994 Jan; 45(1):58-65.
    View in: PubMed
    Score: 0.006
  60. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I. Am J Physiol Renal Physiol. 2013 Dec 01; 305(11):F1574-84.
    View in: PubMed
    Score: 0.006
  61. Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int. 2012 Jun; 81(11):1140-8.
    View in: PubMed
    Score: 0.005
  62. Stone-forming potential of milk or calcium-fortified orange juice in idiopathic hypercalciuric adults. Kidney Int. 1992 Jan; 41(1):139-42.
    View in: PubMed
    Score: 0.005
  63. Solute kinetics with short-daily home hemodialysis using slow dialysate flow rate. Hemodial Int. 2010 Jan; 14(1):39-46.
    View in: PubMed
    Score: 0.004
  64. Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int. 2009 Nov; 76(10):1081-8.
    View in: PubMed
    Score: 0.004
  65. A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am J Physiol Renal Physiol. 2009 Oct; 297(4):F1017-23.
    View in: PubMed
    Score: 0.004
  66. Gestational hypercalciuria causes pathological urine calcium oxalate supersaturations. Kidney Int. 1989 Jul; 36(1):108-13.
    View in: PubMed
    Score: 0.004
  67. In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque. BJU Int. 2010 Jan; 105(2):242-5.
    View in: PubMed
    Score: 0.004
  68. The risks of oral contraceptives and estrogen replacement therapy. Perspect Biol Med. 1989; 33(1):86-106.
    View in: PubMed
    Score: 0.004
  69. A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int. 2009 Apr; 103(7):966-71.
    View in: PubMed
    Score: 0.004
  70. Prevalence of hyperoxaluria after bariatric surgery. J Urol. 2009 Jan; 181(1):161-6.
    View in: PubMed
    Score: 0.004
  71. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int. 2009 Mar; 103(5):670-8.
    View in: PubMed
    Score: 0.004
  72. Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Renal Physiol. 2008 Nov; 295(5):F1286-94.
    View in: PubMed
    Score: 0.004
  73. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant. 2009 Jan; 24(1):130-6.
    View in: PubMed
    Score: 0.004
  74. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int. 1988 Jun; 33(6):1140-6.
    View in: PubMed
    Score: 0.004
  75. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int. 2008 Jul; 74(2):223-9.
    View in: PubMed
    Score: 0.004
  76. Pathophysiology of kidney stones and strategies for treatment. Hosp Pract (Off Ed). 1988 Mar 15; 23(3):185-9, 193-5, 199-200 passim.
    View in: PubMed
    Score: 0.004
  77. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken). 2008 Mar; 291(3):325-34.
    View in: PubMed
    Score: 0.004
  78. Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis. Kidney Int. 1987 Nov; 32(5):749-53.
    View in: PubMed
    Score: 0.004
  79. Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int. 2007 Dec; 72(12):1503-11.
    View in: PubMed
    Score: 0.004
  80. The pathogenesis of calyceal diverticular calculi. Urol Res. 2007 Feb; 35(1):35-40.
    View in: PubMed
    Score: 0.004
  81. Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int. 2007 Apr; 71(8):795-801.
    View in: PubMed
    Score: 0.004
  82. A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int. 1986 Jul; 30(1):85-90.
    View in: PubMed
    Score: 0.003
  83. Is estrogen preferable to surgery for postmenopausal women with primary hyperparathyroidism? N Engl J Med. 1986 Jun 05; 314(23):1508-9.
    View in: PubMed
    Score: 0.003
  84. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. BJU Int. 2006 Jun; 97(6):1285-90.
    View in: PubMed
    Score: 0.003
  85. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest. 1986 Jun; 77(6):1888-96.
    View in: PubMed
    Score: 0.003
  86. Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int. 2006 Jun; 69(12):2227-35.
    View in: PubMed
    Score: 0.003
  87. Recurrent renal calculi. Causes and prevention. Hosp Pract (Off Ed). 1986 Mar 30; 21(3A):49-57.
    View in: PubMed
    Score: 0.003
  88. Urinary cystine excretion and capacity in patients with cystinuria. Kidney Int. 2006 Mar; 69(6):1041-7.
    View in: PubMed
    Score: 0.003
  89. Urine citrate and calcium in calcium nephrolithiasis. Adv Exp Med Biol. 1986; 208:445-9.
    View in: PubMed
    Score: 0.003
  90. Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis. J Clin Invest. 1985 Oct; 76(4):1455-62.
    View in: PubMed
    Score: 0.003
  91. Effects of dietary calcium restriction on 1,25-dihydroxyvitamin D3 net synthesis by rat proximal tubules. J Lab Clin Med. 1985 Sep; 106(3):286-92.
    View in: PubMed
    Score: 0.003
  92. Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis. 2005 Aug; 46(2):263-9.
    View in: PubMed
    Score: 0.003
  93. Role of fetal 1,25-dihydroxyvitamin D production in intrauterine phosphorus and calcium homeostasis. Pediatr Res. 1985 Jun; 19(6):566-9.
    View in: PubMed
    Score: 0.003
  94. Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int. 2005 Feb; 67(2):576-91.
    View in: PubMed
    Score: 0.003
  95. Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab. 1985; 11(4):267-9.
    View in: PubMed
    Score: 0.003
  96. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int. 2004 Aug; 66(2):777-85.
    View in: PubMed
    Score: 0.003
  97. Elevated 1,25(OH)2D3, intestinal absorption, and renal mineral conservation in male rats. Am J Physiol. 1984 Feb; 246(2 Pt 2):F140-5.
    View in: PubMed
    Score: 0.003
  98. Secondary hyperparathyroidism in children with symptomatic idiopathic hypercalciuria. J Pediatr. 1983 Dec; 103(6):932-5.
    View in: PubMed
    Score: 0.003
  99. Effects of calcium intake on 1,25-dihydroxyvitamin D3 net synthesis by rat proximal tubules. Trans Assoc Am Physicians. 1983; 96:225-33.
    View in: PubMed
    Score: 0.003
  100. Hyperuricosuria and calcium nephrolithiasis. Urol Clin North Am. 1981 Jun; 8(2):227-44.
    View in: PubMed
    Score: 0.002
  101. Nephrolithiasis: causes, classification, and management. Hosp Pract (Hosp Ed). 1981 Apr; 16(4):33-45.
    View in: PubMed
    Score: 0.002
  102. Acclerated calcium nephrolithiasis. JAMA. 1980 Aug 22-29; 244(8):809-10.
    View in: PubMed
    Score: 0.002
  103. Stone disease in hereditary distal renal tubular acidosis. Ann Intern Med. 1980 Jul; 93(1):60-1.
    View in: PubMed
    Score: 0.002
  104. Uric acid saturation in calcium nephrolithiasis. Kidney Int. 1980 May; 17(5):662-8.
    View in: PubMed
    Score: 0.002
  105. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease. Scand J Urol Nephrol Suppl. 1980; 53:171-7.
    View in: PubMed
    Score: 0.002
  106. Hyperuricosuric calcium oxalate nephrolithiasis. Adv Exp Med Biol. 1980; 128:439-50.
    View in: PubMed
    Score: 0.002
  107. Familial idiopathic hypercalciuria. N Engl J Med. 1979 Feb 15; 300(7):337-40.
    View in: PubMed
    Score: 0.002
  108. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Kidney Int. 1999 Feb; 55(2):602-12.
    View in: PubMed
    Score: 0.002
  109. Calcium-uric acid nephrolithiasis. Arch Intern Med. 1978 Jul; 138(7):1090-3.
    View in: PubMed
    Score: 0.002
  110. Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int. 1978 May; 13(5):418-26.
    View in: PubMed
    Score: 0.002
  111. Nephrolithiasis during pregnancy. N Engl J Med. 1978 Feb 09; 298(6):324-6.
    View in: PubMed
    Score: 0.002
  112. Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int. 1998 Jan; 53(1):194-9.
    View in: PubMed
    Score: 0.002
  113. Metabolic acidosis after sulfur ingestion. N Engl J Med. 1977 Oct 20; 297(16):869-70.
    View in: PubMed
    Score: 0.002
  114. The natural history of calcium urolithiasis. JAMA. 1977 Oct 03; 238(14):1519-23.
    View in: PubMed
    Score: 0.002
  115. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med. 1977 Oct; 87(4):404-10.
    View in: PubMed
    Score: 0.002
  116. Treatment of hypertension by computer and physician-a prospective controlled study. J Chronic Dis. 1977 Feb; 30(2):81-92.
    View in: PubMed
    Score: 0.002
  117. Evidence for mild reversible hyperparathyroidism in distal renal tubular acidosis. Arch Intern Med. 1975 Nov; 135(11):1485-9.
    View in: PubMed
    Score: 0.002
  118. Effect of acute and chronic metabolic acidosis on serum immunoreactive parathyroid hormone in man. Kidney Int. 1975 Oct; 8(4):263-73.
    View in: PubMed
    Score: 0.002
  119. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med. 1974 Dec 19; 291(25):1344-50.
    View in: PubMed
    Score: 0.002
  120. Magnitude of metabolic acidosis in primary hyperparathyroidism. Arch Intern Med. 1974 Aug; 134(2):262-5.
    View in: PubMed
    Score: 0.002
  121. The performance of a computer system for metabolic assessment of patients with nephrolithiasis. Comput Biomed Res. 1974 Feb; 7(1):40-55.
    View in: PubMed
    Score: 0.001
  122. Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet. 1973 Jan 20; 1(7795):129-31.
    View in: PubMed
    Score: 0.001
  123. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest. 1973 Jan; 52(1):134-42.
    View in: PubMed
    Score: 0.001
  124. Hyperparathyroidism in idiopathic hypercalciuria: primary or secondary? Trans Assoc Am Physicians. 1971; 84:152-61.
    View in: PubMed
    Score: 0.001
  125. Mechanism of monomethylhydrazine excretion by the mammalian kidney. J Pharmacol Exp Ther. 1968 Sep; 163(1):216-21.
    View in: PubMed
    Score: 0.001
  126. The effect of hydrazine upon renal excretion of sodium, potassium and water. J Pharmacol Exp Ther. 1968 May; 161(1):183-90.
    View in: PubMed
    Score: 0.001
  127. Nephrolithiasis and gestation. Baillieres Clin Obstet Gynaecol. 1987 Dec; 1(4):909-19.
    View in: PubMed
    Score: 0.001
  128. Nephrolithiasis in pregnancy. Am J Kidney Dis. 1987 Apr; 9(4):354-8.
    View in: PubMed
    Score: 0.001
  129. Mechanism of hydrazine excretion by the mammalian kidney. Am J Physiol. 1967 Feb; 212(2):394-9.
    View in: PubMed
    Score: 0.001
  130. Preliminary report of a new treatment strategy for advanced pelvic malignancy: surgical resection and radiation therapy using afterloading catheters plus an inflatable displacement prosthesis in the treatment of advanced primary and recurrent rectal cancer. Surgery. 1986 Sep; 100(3):494-9.
    View in: PubMed
    Score: 0.001
  131. Effect of atrial natriuretic factor in rat pregnancy. Am J Physiol. 1986 Apr; 250(4 Pt 2):R589-94.
    View in: PubMed
    Score: 0.001
  132. Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis. Trans Assoc Am Physicians. 1985; 98:281-9.
    View in: PubMed
    Score: 0.001
  133. Calcium nephrolithiasis and medullary sponge kidney in women. N Engl J Med. 1982 May 06; 306(18):1088-91.
    View in: PubMed
    Score: 0.001
  134. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients. Arch Intern Med. 1982 Mar; 142(3):504-7.
    View in: PubMed
    Score: 0.001
  135. Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med. 1982 Jan; 72(1):17-24.
    View in: PubMed
    Score: 0.001
  136. Hyperparathyroidism in nephrolithiasis. Arch Intern Med. 1980 Nov; 140(11):1479-81.
    View in: PubMed
    Score: 0.001
  137. Urinary saturation measurements in calcium nephrolithiasis. Ann Intern Med. 1979 Feb; 90(2):180-4.
    View in: PubMed
    Score: 0.001
  138. Idiopathic hypercalciuria in children: prevalence and metabolic characteristics. J Pediatr. 1978 Jun; 92(6):906-10.
    View in: PubMed
    Score: 0.000
  139. Maternal primary hyperparathyroidism of pregnancy. Successful treatment by parathyroidectomy. JAMA. 1977 Aug 08; 238(6):508-9.
    View in: PubMed
    Score: 0.000
  140. Diseases associated with calcium pyrophosphate dihydrate crystal deposition. Am J Med. 1974 May; 56(5):704-14.
    View in: PubMed
    Score: 0.000
  141. Hemodialysis in children: technique, kinetic aspects related to varying body size, and application to salicylate intoxication, acute renal failure and some other disorders. Medicine (Baltimore). 1966 Jan; 45(1):1-50.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.